4//SEC Filing
Edwards Lifesciences Corp 4
Accession 0001225208-12-016927
$EWCIK 0001099800operating
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 9:04 PM ET
Size
14.4 KB
Accession
0001225208-12-016927
Insider Transaction Report
Form 4
GARREN BRUCE P
CVP, Gov. Affairs/Gen. Counsel
Transactions
- Exercise/Conversion
Common Stock
2012-07-30$27.77/sh+21,000$583,170→ 83,748 total - Sale
Common Stock
2012-07-30$105.21/sh−500$52,605→ 93,248 total - Sale
Common Stock
2012-07-30$104.34/sh−30,500$3,182,370→ 62,748 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2012-07-30−21,000→ 0 totalExercise: $27.77From: 2009-05-08Exp: 2015-05-07→ Common Stock (21,000 underlying) - Exercise/Conversion
Common Stock
2012-07-30$24.42/sh+10,000$244,200→ 93,748 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2012-07-30−10,000→ 15,000 totalExercise: $24.42From: 2008-05-10Exp: 2014-05-09→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.
- [F2]This transaction was executed in multiple trades at prices ranging from $105.20 to $105.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $104.07 to $104.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001099800
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 9:04 PM ET
- Size
- 14.4 KB